Capstone Holding Corp. (CAPS)

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2018	Dec 31, 2002	Dec 31, 2001	Dec 31, 2000
Novel Peptides and Other Molecules	48.35M
Novel Peptides and Other Molecules Growth	-21.45%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2018	Dec 31, 2002	Dec 31, 2001	Dec 31, 2000
United States	48.35M
United States Growth	-21.45%